Menu

CDC Director Resigns Over Unresolved Conflicts of Interest

Brenda Fitzgerald had drawn criticism for tobacco-related investments, among others.

Jan 31, 2018
Shawna Williams

FLICKR, RAED MANSOURFollowing a report by Politico that she had purchased shares in tobacco, pharmaceutical, and health insurance companies early in her tenure as director of the Centers for Disease Control (CDC), Brenda Fitzgerald resigned from the agency today (January 31). Fitzgerald had previously been criticized by Senator Patty Murray (D-WA) for financial investments that led her to recuse herself from involvement in some aspects of CDC’s work, The Washington Post reports.

See “Trump Administration Chooses New CDC Director

“You don’t buy tobacco stocks when you are the head of the CDC,” Richard Painter, a former chief ethics lawyer for George W. Bush, tells Politico. “It’s ridiculous; it gives a terrible appearance.”

According to a Department of Health and Human Services statement announcing the departure, “Dr. Fitzgerald owns certain complex financial interests that have imposed a broad recusal limiting her ability to complete all of her duties as the CDC Director. Due to the nature of these financial interests, Dr. Fitzgerald could not divest from them in a definitive time period.”

Before assuming the CDC post in July 2017, Fitzgerald had worked as an obstetrician-gynecologist. She had also served as a major in the Air Force and as chief of Georgia’s state health department.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!